Brent Hatzis-Schoch
Fortune : 58 969 $ au 31/07/2026
Fortune : 58 969 $ au 31/07/2026
Brent Hatzis-Schoch is currently Chief Operating Officer & General Counsel at Black Diamond Therapeutics, Inc. since 2019.
Former roles include Director at Ulthera, Inc.; Legal Counsel at Baxter International, Inc. from 1994 to 1998; Secretary, Senior Vice President & General Counsel at Radius Health, Inc. from 2017 to 2019; General Counsel at GPC Biotech AG from 2003 to 2009; Associate General Counsel at Pharmacia Corp.
from 1998 to 2003; General Counsel at Agennix AG from 2009 to 2013; and Chief Legal Counsel & Senior Vice President at Merz Pharma GmbH & Co. KGaA from 2013 to 2015.
Education includes graduate studies at George Washington University and undergraduate studies at the University of Delaware.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/04/2026 | 34 893 ( 0,06 % ) | 58 969 $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Directeur des opérations | 29/05/2019 |
| Sociétés | Poste | Fin |
|---|---|---|
| RADIUS HEALTH, INC. | Conseiller Juridique Général | 10/05/2019 |
Merz Pharma GmbH & Co. KGaA
Merz Pharma GmbH & Co. KGaA Miscellaneous Commercial ServicesCommercial Services Researches, develops, and sells drugs for the treatment of disorders in the area of neurology, psychiatry, dermatology | Conseiller Juridique Général | 01/04/2015 |
| AGENNIX AG | Conseiller Juridique Général | 01/01/2013 |
GPC Biotech AG
GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes new anticancer drugs | Conseiller Juridique Général | 01/01/2009 |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Corporate Officer/Principal | 01/01/2003 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 10 |
|---|---|
Baxter International, Inc.
Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
Ulthera, Inc.
Ulthera, Inc. Medical SpecialtiesHealth Technology Develops and markets medical devices | Health Technology |
GPC Biotech AG
GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes new anticancer drugs | Commercial Services |
George Washington University
George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
University of Delaware
University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Agennix AG
Agennix AG BiotechnologyHealth Technology Discovers, develops and commercializes new anti-cancer drugs | Health Technology |
Merz Pharma GmbH & Co. KGaA
Merz Pharma GmbH & Co. KGaA Miscellaneous Commercial ServicesCommercial Services Researches, develops, and sells drugs for the treatment of disorders in the area of neurology, psychiatry, dermatology | Commercial Services |
Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops precision medicines for cancer | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national